Latest updates for Zint:ca
Fresh curated links around ZINT:CA are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Philip Morris International Inc. 2026 Q3 - Results - Earnings Call Presentation
- Zentalis at Morgan Stanley conference: azenosertib push gains shape
- Zentalis Pharmaceuticals, Inc. (ZNTL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Zentalis at Morgan Stanley conference: azenosertib push gains shape
Zentalis Pharmaceuticals, Inc. (ZNTL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Zymeworks: Transitioning Into A Royalty-Driven Biopharma Platform Post Ziihera Approval
Philip Morris International Inc. (PM) Q3 2026 Earnings Call Transcript
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Zanvastro]]>
How Lead, Silver And Copper Credits Are Reshaping Zinc Mine Profitability
Just Ingredients NAD+ Complex Features Compound Solutions' Newly Patented NAD3®
The daily longevity capsule pairs NAD3® with nicotinamide riboside and organic resveratrol, anchoring the formula in mitochondrial function rather than NAD+ levels alone. CARLSBAD...
Ingevity: Portfolio Simplification Reveals A High-Margin Regulatory Compounder
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.